TCF7 and cancer: Both of these studies attribute the sex bias in cancer to AR-mediated regulation of Tcf7/TCF1 in CD8+ T cells and the subsequent differentiation to dysfunctional T cells; however, the former ascribed a positive regulatory role while the latter a negative regulatory role.